Skip to main content
OpenTrials
Completed

NCT Number: NCT02951923

The Effect of 8-weeks of Bovine Colostrum and Soy Protein Supplementation in Rugby Players

Bovine colostrum is the milk produced by cows immediately after calving. It contains high levels of proteins that improve immune protection and may act to prevent colds. During intense training, athletes often have compromised immune function. This may be especially true in club-level rugby players who abruptly start high intensity training in the spring in preparation for their competitive season. Our study will assess the effects of supplementing these players with bovine colostrum during this intense training. Thirty-six players will be recruited; half will consume colostrum during the 8 weeks of early-season training and half soy protein. The investigators predict the bovine colostrum supplement will improve health during the training and increase fitness levels.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

College of Kinesiology, University of Saskatchewan

Saskatoon, Saskatchewan, S7N 5B2, Canada

About this study

Bovine colostrum is the first milk secreted by cows after calving. Colostrum is high in protein and contains a number of bioactive substances including growth and antimicrobial factors. Antimicrobial factors in bovine colostrum include immunoglobulin and a variety of other less specific antimicrobial proteins and peptides. Immunoglobulin and other antimicrobials are important for immune system function. This is important to athletes because intense exercise training can compromise the immune system; therefore bovine colostrum has potential to improve exercise performance by preventing immune system dysfunction that is common during periods of heavy exercise training .

Preliminary studies of colostrum supplementation show its potential for increasing human exercise performance. The mechanism through which colostrum acts to benefit performance remains unclear. Similarly, further studies are required to elucidate colostrum-induced effects in individuals of different ages and levels/intensity of physical activity.

The main growth factor in bovine colostrum is insulin-like growth factor-1 (IGF-1). Bovine colostrum supplementation in young individuals increased IGF-1 levels. Insulin-like growth factor-1 stimulates growth of muscle tissue and is important in maintaining muscle mass and function in adults.

Bovine colostrum supplementation has been shown to increase lean tissue (muscle mass) in younger individuals. Eight to 12 weeks of bovine colostrum supplementation during a resistance training program increased lean tissue mass by 1.5 to 2 kg compared to increases of 0 to 1.2 kg while on whey protein supplementation. We have also recently shown that bovine colostrum supplementation increases muscular strength compared to similar amounts of supplementation with whey protein in men and women over 50y.

Examining the effects of colostrum in rugby players presents a unique scientific opportunity because of the nature of their training regime. Rugby players' early season workouts are the most stressful training sessions of the season (after the winter break they must condition quickly for the start of the season with few if any pre-season games and their workouts involve repeated sprint activity in addition to weight training). Rugby players would be most susceptible to overtraining and immune system depression during this time of the year. Bovine colostrum with its high levels of anti-microbials and other bioactive factors may be beneficial to mitigate the deleterious effects of early, high intensity training.

The objective of the proposed internship study is to determine the effects of 8 weeks of bovine colostrum supplementation, compared to soy protein supplementation in rugby players during early season training.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • active rugby players

Exclusion criteria

  • Not taking nutritional supplements within one month of the study
  • Answered "yes" to a physical activity readiness questionnaire indicating health problems that could be exacerbated with physical activity

Treatment and study plan

Bovine colostrum

Dietary Supplement

Bovine colostrum vs. soy during rugby training

Soy

Dietary Supplement

Primary outcomes

  1. Change in lean tissue mass

    Time frame: baseline, 8 weeks

  2. Change in leg press strength

    Time frame: baseline, 8 weeks

  3. Change in bench press strength

    Time frame: baseline, 8 weeks

  4. Change in aerobic capacity as predicted by the Leger shuttle run test

    Time frame: baseline, 8 weeks

  5. Change in leg power as assessed by vertical jump height

    Time frame: baseline, 8 weeks

Secondary outcomes

  1. Change in salivary immunoglobulin A

    Time frame: baseline, 8 weeks

  2. Change in salivary interleukin 6

    Time frame: baseline, 8 weeks

  3. Change in salivary interleukin 1-beta

    Time frame: baseline, 8 weeks

  4. Change in salivary c-reactive protein

    Time frame: baseline, 8 weeks

  5. Incidence of upper respiratory tract infections

    Time frame: Up to 8 weeks

  6. Adverse events

    Time frame: Up to 8 weeks

Sponsors and collaborators

Lead sponsor

University of Saskatchewan

Other

Registry information

Official study title

The Effect of 8-weeks of Bovine Colostrum and Soy Protein Supplementation on Fitness, Muscle Mass, Inflammation and Immune Function During Intense Training in Rugby Players

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Nov 1, 2016
Registry last updated
Nov 1, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.